SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-15 |
| Reported value | $21,675,731,270 |
| Positions | 89 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| STATE STR SPDR S&P 500 ETF T | SPY | TR UNIT | $4,480,620,000 | 6,000,000 |
| REVOLUTION MEDICINES INC | RVMD | COM | $2,537,793,075 | 13,550,796 |
| ELECTRONIC ARTS INC | Unresolved | COM | $1,623,814,280 | 7,919,500 |
| BRIDGEBIO PHARMA INC | BBIO | COM | $800,143,332 | 10,743,063 |
| PROTAGONIST THERAPEUTICS INC | PTGX | COM | $778,248,897 | 6,348,906 |
| EXELIXIS INC | EXEL | COM | $732,794,424 | 13,468,010 |
| LIQUIDIA CORPORATION | LQDA | COM NEW | $666,944,480 | 8,365,038 |
| AMAZON COM INC | AMZN | COM | $627,547,790 | 2,632,994 |
| LANTHEUS HLDGS INC | LNTH | COM | $619,431,160 | 5,583,479 |
| NATERA INC | NTRA | COM | $602,175,451 | 2,218,366 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.